Cargando…
Neuroprotective mechanisms of 3-n-butylphthalide in neurodegenerative diseases
Since 3-n-butylphthalide (NBP) was approved by the China Food and Drug Administration for the treatment of acute ischemia stroke in 2002, a number of studies have investigated NBP worldwide. In recent years, NBP has also demonstrated potential as treatment of several neurodegenerative diseases, whic...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873419/ https://www.ncbi.nlm.nih.gov/pubmed/31798868 http://dx.doi.org/10.3892/br.2019.1246 |